Related Experiment Video
Updated: Jun 4, 2026
10:39
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Leukotrienes and airway inflammation.
Katsuhide Okunishi1, Marc Peters-Golden
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI 4810--5642, USA.
Biochimica Et Biophysica Acta
|March 1, 2011
Summary
Leukotrienes (LTs) are key in asthma, and while current antagonists offer benefits, new targets in the LT pathway are needed for better asthma control. Future strategies may overcome limitations of existing therapies.
Area of Science:
- Biochemistry of Asthma
- Immunology
- Pharmacology
Background:
- Asthma is a chronic airway inflammatory disease.
- Leukotrienes (LTs) significantly contribute to asthma pathogenesis.
- The leukotriene pathway is relatively steroid-resistant, necessitating alternative treatments.
Purpose of the Study:
- To review the biological effects of LTs in asthma.
- To summarize recent advances in LT receptors.
- To identify novel therapeutic targets within the LT pathway for improved asthma management.
Main Methods:
- Literature review of biological effects of LTs.
- Analysis of recent research on LT receptors.
- Exploration of emerging therapeutic targets in the LT pathway.
Main Results:
- CysLTs play a crucial role in asthma pathology.
- Current cysteinyl LT receptor 1 antagonists (LTRAs) are beneficial but have limitations.
- New LT receptors beyond cysLT1 and cysLT2, and the role of LTB4, are being uncovered.
Conclusions:
- Blockade of cysLT receptor 1 is beneficial for asthma management.
- Limitations of current LTRAs necessitate further research.
- Emerging findings suggest new LT pathway targets for superior asthma control.
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...